New Zealand markets closed
  • NZX 50

    12,036.05
    +12.59 (+0.10%)
     
  • NZD/USD

    0.6496
    +0.0003 (+0.05%)
     
  • NZD/EUR

    0.5970
    +0.0015 (+0.26%)
     
  • ALL ORDS

    7,709.50
    +21.50 (+0.28%)
     
  • ASX 200

    7,493.80
    +25.50 (+0.34%)
     
  • OIL

    79.38
    -1.63 (-2.01%)
     
  • GOLD

    1,943.90
    -2.80 (-0.14%)
     
  • NASDAQ

    12,166.60
    +115.12 (+0.96%)
     
  • FTSE

    7,765.15
    +4.04 (+0.05%)
     
  • Dow Jones

    33,978.08
    +28.67 (+0.08%)
     
  • DAX

    15,150.03
    +17.18 (+0.11%)
     
  • Hang Seng

    22,688.90
    +122.12 (+0.54%)
     
  • NIKKEI 225

    27,382.56
    +19.81 (+0.07%)
     
  • NZD/JPY

    84.3200
    -0.0940 (-0.11%)
     

US Nuclear Corp. Announces Third Quarter 2022 Results

US Nuclear Corp.
US Nuclear Corp.

LOS ANGELES, CA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – US Nuclear Corp. (OTCQB: UCLE), a leading manufacturer of advanced radiation, chemical, and biological detection and UAV instrumentation, recently announced the financial results for the third quarter ended September 30, 2022.

For the nine months ended September 30, 2022:

  • Sales were $1,539,517 up slightly from $1,454,153 for the same period in 2021

  • Gross margins were still strong at 45.6% versus 47.0% for the same period in 2021

  • Net loss of $1,671,743 is a major improvement from $2,390,256 for the same period in 2021

For the three months ended September 30, 2022:

  • Sales were $617,434 compared to $683,771 for the same period in 2021

  • Selling, general, and administrative expense were $695,381 compared to $747,290 for the same period in 2021, the decrease of $51,909 or 7.5% due to the company cutting back on expenses

  • Net loss of $655,822 compared to $444,383 for the same period in 2021

Robert Goldstein, CEO of US Nuclear Corp., commented:

“We had a strong third quarter and have executed well this year despite facing challenging conditions such as supply chain shortages and rising cost of parts and skilled labor. We continue to reduce our operating costs and have also recently increased the prices we charge for all our products and services. As nuclear energy becomes more popular and as fears of chemical-nuclear war or terrorism mount, we have seen an increase in demand for our equipment that continues to grow. We are especially excited about our DroneRAD platform and the advanced chemical detection capability it now has (can even detect explosives, war gases, and drugs such as fentanyl), as well as the introduction of industry’s first and only portable PFAS monitors to quickly measure the toxic ‘forever chemicals’.”


US NUCLEAR CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

 

 

September 30,

 

September 30,

 

 

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

 

$

617,434

 

$

683,771

 

$

1,539,517

 

$

1,454,153

 

Cost of sales

 

405,471

 

 

357,426

 

 

837,523

 

 

770,780

 

Gross profit

 

 

211,963

 

 

326,345

 

 

701,994

 

 

683,373

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

695,381

 

 

747,290

 

 

2,103,637

 

 

2,228,295

 

 

 

Total operating expenses

 

695,381

 

 

747,290

 

 

2,103,637

 

 

2,228,295

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(483,419

)

 

(420,945

)

 

(1,401,644

)

 

(1,544,922

)

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense)

 

 

 

 

 

 

 

 

 

Interest expense

 

(31,710

)

 

(3,016

)

 

(37,650

)

 

(9,872

)

 

Equity loss in investment

 

-

 

 

(20,422

)

 

-

 

 

(835,462

)

 

Expense for debt issuance

 

-

 

 

-

 

 

-

 

 

-

 

 

Amortization of debt discount

 

(140,693

)

 

-

 

 

(232,449

)

 

-

 

 

 

Total other income (expense)

 

(172,403

)

 

(23,438

)

 

(270,099

)

 

(845,334

)

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

(655,822

)

 

(444,383

)

 

(1,671,743

)

 

(2,390,256

)

 

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

-

 

 

-

 

 

-

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(655,822

)

$

(444,383

)

$

(1,671,743

)

$

(2,390,256

)

 

 

 

 

 

 

 

 

 

 

 

 

Deemed dividend for downround provision in warrants

 

 

 

 

 

(9,652

)

 

(52,861

)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributed to common stockholders

$

(655,822

)

$

(444,383

)

$

(1,681,395

)

$

(2,443,117

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic and diluted

 

29,504,433

 

 

27,914,302

 

 

28,923,132

 

 

27,072,892

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per shares - basic and diluted

$

(0.02

)

$

(0.02

)

$

(0.06

)

$

(0.09

)

 

 

 

 

 

 

 

 

 

 

 

 

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com.

CONTACT:

US Nuclear Corp. (OTC-QB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Richard Landry, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com
http://usnuclearcorp.com
http://tech-associates.com
http://overhoff.com